Biggest News Aggregation in the World

Page 4 - Patrick Lu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Patrick Lu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Patrick Lu Today - Breaking & Trending Today

Sirnaomics Accelerates Clinical Development of STP705 for the Treatment of Non-Melanoma Skin Cancers

Published: February 1, 2023

/PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi...

Source: prnewswire.com

Related Topics:

Sirnaomics Announces Interim Data from Phase I Clinical Trial of RNAi Therapeutic STP707 for Treatment of Multiple Solid Tumors

Published: December 20, 2022

/PRNewswire/ -- Sirnaomics Ltd. (Stock Code: 2257.HK) (the "Company", together with its subsidiaries, "Sirnaomics" or the "Group"), a leading biopharmaceutical...

Source: prnewswire.com

Related Topics:

United States Nigel Yip Bunny Lee Alexis Feinberg Michael Molyneaux Patrick Lu Lysine Co Sirnaomics Ltd Prnewswire Sirnaomics Ltd Stock Code Executive Director Chief Medical Officer Histidine Lysine Co Polymer Financial Officer Media Contact Sirnaomics Ltd

Sirnaomics Announces Positive Interim Data from Phase IIb Clinical Trial of STP705 in Adults with Cutaneous Squamous Cell Carcinoma In Situ

Published: December 14, 2022

/PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi...

Source: prnewswire.com

Related Topics:

Michael Molyneaux Patrick Lu International Agency For Research On Cancer Chinese National Medical Products Administration A World Health Organization Drug Administration Prnewswire Sirnaomics Ltd Company Or Sirnaomics Cutaneous Squamous Cell Carcinoma In Situ Executive Director Basal Cell Carcinoma Sirnaomics News Release Squamous Cell Carcinoma Chief Medical Officer Local Skin Response Scores Extramammary Paget World Health Organization Orphan Drug Designation Sirnaomics Ltd

Sirnaomics Doses the First Patient in Phase I Clinical Trial of RNAi Therapeutic STP705 in Adults Undergoing Abdominoplasty for Medical Aesthetics Treatment

Published: November 7, 2022

/PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi...

Source: prnewswire.com

Sirnaomics to Present at 3rd Annual Jefferies Asia Forum

Published: September 7, 2022

/PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi...

Source: prnewswire.com

Related Topics:

United States Nigel Yip Mark Corbae Bunny Lee Patrick Lu Jefferies Asia Forum Sirnaomics Ltd Prnewswire Sirnaomics Ltd Executive Director Annual Jefferies Asia Forum Sirnaomic Investor Relations Financial Officer Media Contact Sirnaomics Ltd Health Care Amp Hospitals Medical Pharmaceuticals Pharmaceuticals Trade Show News

Page 5 Page 6 Page 7 Page 8